CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.
November 21st 2024
Aerobic exercise improved self-reported cognitive function in women undergoing chemotherapy for breast cancer but had no effect on objective cognitive function.
Adding Ibrance to Faslodex Delays Progression of Hormone Receptor-Positive Breast Cancer
June 1st 2015By adding the targeted drug Ibrance to the hormonal drug Faslodex, women with previously treated hormone receptor (HR)-positive, HER2-negative breast cancer delayed disease progression by more than five months.
Two-Pronged Strategy With PARP Inhibitor Gains Traction in Breast and Ovarian Cancers
May 8th 2015A two-pronged strategy combining the PARP inhibitor Lynparza and the PI3K inhibitor BKM120 proved to be a safe and clinically beneficial regimen for women with TNBC and for patients with high-grade serous ovarian cancer.
Early Phase Study Shows MM-302 Has Activity in Heavily-Pretreated HER2-Positive Breast Cancer
April 20th 2015MM-302, a novel antibody-drug conjugate that specifically targets cancer cells overexpressing the HER2 receptor, showed signs of clinical activity in heavily pretreated patients with metastatic, HER2-positive breast cancer.
Telephone Intervention Helps Breast Cancer Survivors Set—and Meet—Lifestyle Goals
April 15th 2015A new telephone-based intervention for breast cancer survivors is showing promise, and it involves them becoming more actively engaged in goal setting and problem solving with an eye toward accelerating their recovery by engaging in health-promoting activities such as exercise, stress management and healthy eating.
An Unmet Need—Discussing Genetic Risk May Benefit All Patients With Breast Cancer
April 10th 2015Many women who are diagnosed with breast cancer are concerned about the genetic risk of developing other cancers themselves or of a loved one developing cancer. However, a large amount of those concerns are not being addressed, according to a new study.